Dutch remote monitoring and sleep aid company, Onera Health’s wireless, patch-based, type-II home-polysomnography system has proven to be as beneficial as in-hospital testing in a validation study.

The global home sleep apnea testing market is on a trajectory of steady expansion, with sales projected to grow from an estimated USD 712.3 million in 2025 to USD 966.1 million by 2035. The market is ...

"However, the current gold standard, polysomnography, is expensive, complicated, and is not suitable for long-term home use ... researchers developed fabric-based sensors that detect subtle ...